Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer
Sponsor: Rigshospitalet, Denmark
This NA trial investigates Lower Urinary Tract Symptoms and Prostatic Diseases and is currently completed. Rigshospitalet, Denmark leads this study, which shows 8 recorded versions since 2017 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Dec 2018 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2018 — Dec 2018 [monthly]
Active Not Recruiting NA
▶ Show 3 earlier versions
-
Jul 2018 — Sep 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting NA
-
May 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Mar 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Rigshospitalet, Denmark
For direct contact, visit the study record on ClinicalTrials.gov .